• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物伦理学与健康人文学科中的人工智能政策:出版商与期刊的比较分析

Artificial intelligence policies in bioethics and health humanities: a comparative analysis of publishers and journals.

作者信息

Bobier Christopher, Rodger Daniel, Hurst Daniel

机构信息

Central Michigan University College of Medicine, Mount Pleasant, USA.

London South Bank University, London, UK.

出版信息

BMC Med Ethics. 2025 Jul 3;26(1):79. doi: 10.1186/s12910-025-01239-9.

DOI:10.1186/s12910-025-01239-9
PMID:40611206
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12226874/
Abstract

INTRODUCTION

Rapid advancements in artificial intelligence (AI) pose novel ethical and practical challenges for scholarly publishing. Although AI-related policies are emerging in many disciplines, little is known about the extent and clarity of AI guidance in bioethics and health humanities journals.

METHODS

A search of publicly available journal lists from the American Society for Bioethics and Humanities, Health Humanities Consortium, and Association for Medical Humanities was supplemented with Google Scholar's top 20 bioethics journals ranked by h5-index. This yielded 54 unique journals, of which 50 remained after excluding those without a functional website or recent publications. AI policies were reviewed at the journal and publisher levels were assessed via website review, and editors were contacted for clarification when required. Data extraction was conducted by one author and independently verified by two additional researchers to ensure accuracy.

RESULTS

Of the 50 journals analyzed, only 8 (16%) had a clear AI policy, while 27 (54%) were published by a publisher with an identifiable AI policy. Publisher AI policy statements were favorable to considering AI-assisted manuscripts. Five (10%) of the 8 journals with a clear AI policy explicitly prohibited AI-generated text in submissions. The remaining 15 (30%) journals did not have a publicly available AI policy. Ten of these 15 journals confirmed an absence of any formal AI policy, and seven indicated that discussion to develop guidelines was ongoing.

CONCLUSION

The adoption of AI policies in bioethics and health humanities journals is currently inconsistent. Some journals explicitly ban AI-generated text, whereas others permit AI-assisted writing, with publisher policies being favorable to considering AI-assisted manuscripts. The lack of standardized AI guidelines underscores the need for further discussion to ensure the ethical and responsible integration of AI in academic publishing.

摘要

引言

人工智能(AI)的快速发展给学术出版带来了新的伦理和实际挑战。尽管许多学科都在出台与人工智能相关的政策,但对于生物伦理学和健康人文学科期刊中人工智能指导的范围和清晰度却知之甚少。

方法

通过搜索美国生物伦理学与人文学会、健康人文学科联盟和医学人文协会公开的期刊列表,并补充谷歌学术按h5指数排名的前20种生物伦理学期刊。这产生了54种独特的期刊,排除那些没有正常运行网站或近期出版物的期刊后,还剩下50种。通过网站审查评估期刊和出版商层面的人工智能政策,必要时联系编辑进行澄清。数据提取由一位作者进行,并由另外两位研究人员独立核实以确保准确性。

结果

在分析的50种期刊中,只有8种(16%)有明确的人工智能政策,而27种(54%)由有明确人工智能政策的出版商出版。出版商的人工智能政策声明有利于考虑人工智能辅助撰写的稿件。8种有明确人工智能政策的期刊中有5种(10%)明确禁止投稿中出现人工智能生成的文本。其余15种(30%)期刊没有公开的人工智能政策。这15种期刊中有10种确认没有任何正式的人工智能政策,7种表示正在讨论制定指导方针。

结论

生物伦理学和健康人文学科期刊目前对人工智能政策的采用并不一致。一些期刊明确禁止人工智能生成的文本,而另一些则允许人工智能辅助写作,出版商的政策有利于考虑人工智能辅助撰写的稿件。缺乏标准化的人工智能指导方针凸显了进一步讨论的必要性,以确保人工智能在学术出版中的伦理和负责任的整合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b26c/12226874/31fbb54f499c/12910_2025_1239_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b26c/12226874/31fbb54f499c/12910_2025_1239_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b26c/12226874/31fbb54f499c/12910_2025_1239_Fig1_HTML.jpg

相似文献

1
Artificial intelligence policies in bioethics and health humanities: a comparative analysis of publishers and journals.生物伦理学与健康人文学科中的人工智能政策:出版商与期刊的比较分析
BMC Med Ethics. 2025 Jul 3;26(1):79. doi: 10.1186/s12910-025-01239-9.
2
Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.试验报告的统一标准(CONSORT)以及医学期刊上发表的随机对照试验(RCT)的报告完整性。
Cochrane Database Syst Rev. 2012 Nov 14;11(11):MR000030. doi: 10.1002/14651858.MR000030.pub2.
3
Do peer reviewers comment on reporting items as instructed by the journal? A secondary analysis of two randomized trials.同行评审员是否按照期刊的要求对报告项目进行评论?两项随机试验的二次分析。
J Clin Epidemiol. 2025 May 8;183:111818. doi: 10.1016/j.jclinepi.2025.111818.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Defining the Boundaries of AI Use in Scientific Writing: A Comparative Review of Editorial Policies.界定科学写作中人工智能使用的界限:编辑政策的比较综述
J Korean Med Sci. 2025 Jun 16;40(23):e187. doi: 10.3346/jkms.2025.40.e187.
6
Interventions to prevent misconduct and promote integrity in research and publication.预防科研与出版领域不当行为并促进诚信的干预措施。
Cochrane Database Syst Rev. 2016 Apr 4;4(4):MR000038. doi: 10.1002/14651858.MR000038.pub2.
7
Manipulative therapies for infantile colic.婴儿腹绞痛的手法治疗
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD004796. doi: 10.1002/14651858.CD004796.pub2.
8
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
9
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.

本文引用的文献

1
The ethics of using artificial intelligence in scientific research: new guidance needed for a new tool.科学研究中使用人工智能的伦理问题:新工具需要新指南。
AI Ethics. 2025 Apr;5(2):1499-1521. doi: 10.1007/s43681-024-00493-8. Epub 2024 May 27.
2
Disclosing artificial intelligence use in scientific research and publication: When should disclosure be mandatory, optional, or unnecessary?披露科学研究与出版中人工智能的使用情况:何时披露应为强制、自愿或无需披露?
Account Res. 2025 Mar 24:1-13. doi: 10.1080/08989621.2025.2481949.
3
An overview of studies assessing predatory journals within the biomedical sciences.
评估生物医学领域掠夺性期刊的研究综述。
Account Res. 2025 Feb 24:1-20. doi: 10.1080/08989621.2025.2465625.
4
How are researchers using AI? Survey reveals pros and cons for science.研究人员如何使用人工智能?调查揭示了其对科学的利弊。
Nature. 2025 Feb 4. doi: 10.1038/d41586-025-00343-5.
5
The ethics of disclosing the use of artificial intelligence tools in writing scholarly manuscripts.在撰写学术手稿时披露使用人工智能工具的伦理问题。
Res Ethics. 2023 Oct;19(4):449-465. doi: 10.1177/17470161231180449. Epub 2023 Jun 15.
6
Use of Artificial Intelligence in Peer Review Among Top 100 Medical Journals.人工智能在排名前100的医学期刊同行评审中的应用。
JAMA Netw Open. 2024 Dec 2;7(12):e2448609. doi: 10.1001/jamanetworkopen.2024.48609.
7
Reporting guidelines in medical artificial intelligence: a systematic review and meta-analysis.医学人工智能报告指南:系统评价与荟萃分析
Commun Med (Lond). 2024 Apr 11;4(1):71. doi: 10.1038/s43856-024-00492-0.
8
Academic publisher guidelines on AI usage: A ChatGPT supported thematic analysis.学术出版商关于人工智能使用的指南:一个基于 ChatGPT 的主题分析。
F1000Res. 2024 Jan 16;12:1398. doi: 10.12688/f1000research.142411.2. eCollection 2023.
9
Publishers' and journals' instructions to authors on use of generative artificial intelligence in academic and scientific publishing: bibliometric analysis.出版商和期刊社关于在学术和科学出版中使用生成式人工智能的作者指南:文献计量分析。
BMJ. 2024 Jan 31;384:e077192. doi: 10.1136/bmj-2023-077192.
10
Towards an AI policy framework in scholarly publishing.迈向学术出版领域的人工智能政策框架。
Trends Cogn Sci. 2024 Feb;28(2):85-88. doi: 10.1016/j.tics.2023.12.002. Epub 2024 Jan 8.